Selecting Optimal First-Line Treatment for Microsatellite Stable and Non-Mutated RAS/BRAF Metastatic Colorectal Cancer.
| Publicado en: | Current Treatment Options in Oncology Vol. 24; no. 12; pp. 1739 - 1758 |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Dec2023
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=175409189&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 175409189 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 15272729 3KHC jtl: Current Treatment Options in Oncology issn: 15272729 maglogo: N pubinfo: dt: Dec2023 vid: 24 iid: 12 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 175409189 173624034 10.1007/s11864-023-01142-8 175409189 ppf: 1739 ppct: 19 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Selecting Optimal First-Line Treatment for Microsatellite Stable and Non-Mutated RAS/BRAF Metastatic Colorectal Cancer. aug: au: Emiloju, Oluwadunni E. Zhu, Mojun Xie, Hao Jin, Zhaohui Sinicrope, Frank A. Hubbard, Joleen M. affil: https://ror.org/02qp3tb03 Division of Oncology, Mayo Clinic, 200 First St. SW, 55905, Rochester, MN, USA sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|